• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国40-79岁成年人10年动脉粥样硬化性心血管疾病风险预测:一项全国代表性调查。

Prediction of 10-year Atherosclerotic Cardiovascular Disease Risk among Adults Aged 40-79 Years in China: a Nationally Representative Survey.

作者信息

Zhang Mei, Jiang Yong, Wang Li Min, Li Yi Chong, Huang Zheng Jing, Li Jian Hong, Zhou Mai Geng, Zhao Wen Hua

机构信息

National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China.

Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.

出版信息

Biomed Environ Sci. 2017 Apr;30(4):244-254. doi: 10.3967/bes2017.034.

DOI:10.3967/bes2017.034
PMID:28494834
Abstract

OBJECTIVE

To establish the distribution of 10-year atherosclerotic cardiovascular disease (ASCVD) risk among Chinese adults.

METHODS

We estimated the 10-year ASCVD risk by applying the 2013 American College of Cardiology/ American Heart Association pooled cohort equations (PCEs) to the data obtained from the 2010 China Chronic Disease and Risk Factor Surveillance that involved 61,541 participants (representing 520,158,652 Chinese adults) aged 40-79 years. We also compared the ASCVD risk with the 10-year ischemic cardiovascular disease (ICVD) risk, which was calculated using the simplified scoring tables recommended by the Chinese Guidelines for Prevention of Cardiovascular Diseases (Chinese model).

RESULTS

Based on the PCEs, the average 10-year ASCVD risk among adults without self-reported stroke or myocardial infraction was 12.5%. Approximately 247 million (47.4%) and 107 million (20.6%) adults had ⋝ 7.5% and > 20% 10-year ASCVD risks, respectively. The 10-year ASCVD risk > 20% was higher among men, less educated individuals, smokers, drinkers, and physically inactive individuals than among their counterparts. Overall, 29.0% of adults categorized using the Chinese model were overclassified with the PCEs.

CONCLUSION

Our results define the distribution of 10-year ASCVD risk among Chinese adults. The 10-year ASCVD risk predicted by the PCEs was higher than the ICVD risk predicted by the Chinese model.

摘要

目的

确定中国成年人中10年动脉粥样硬化性心血管疾病(ASCVD)风险的分布情况。

方法

我们将2013年美国心脏病学会/美国心脏协会合并队列方程(PCEs)应用于从2010年中国慢性病与危险因素监测中获取的数据,对61541名年龄在40 - 79岁的参与者(代表520158652名中国成年人)进行分析,以此估算10年ASCVD风险。我们还将ASCVD风险与10年缺血性心血管疾病(ICVD)风险进行了比较,后者是使用《中国心血管病防治指南》推荐的简化评分表(中国模型)计算得出的。

结果

根据PCEs,在没有自我报告中风或心肌梗死的成年人中,平均10年ASCVD风险为12.5%。分别约有2.47亿(47.4%)和1.07亿(20.6%)成年人的10年ASCVD风险≥7.5%和>20%。10年ASCVD风险>20%的情况在男性、受教育程度较低者、吸烟者、饮酒者和缺乏身体活动的个体中高于其对应人群。总体而言,使用中国模型分类的成年人中有29.0%被PCEs过度分类。

结论

我们的结果确定了中国成年人中10年ASCVD风险的分布情况。PCEs预测的10年ASCVD风险高于中国模型预测的ICVD风险。

相似文献

1
Prediction of 10-year Atherosclerotic Cardiovascular Disease Risk among Adults Aged 40-79 Years in China: a Nationally Representative Survey.中国40-79岁成年人10年动脉粥样硬化性心血管疾病风险预测:一项全国代表性调查。
Biomed Environ Sci. 2017 Apr;30(4):244-254. doi: 10.3967/bes2017.034.
2
Prediction of 10-year atherosclerotic cardiovascular disease risk among community residents in Shanghai, China - a comparative analysis of risk algorithms.中国上海社区居民 10 年动脉粥样硬化性心血管疾病风险预测-风险算法的比较分析。
Nutr Metab Cardiovasc Dis. 2021 Jun 30;31(7):2058-2067. doi: 10.1016/j.numecd.2021.04.009. Epub 2021 Apr 20.
3
Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations.使用预测心血管疾病事件方程评估动脉粥样硬化性心血管疾病风险。
JAMA Intern Med. 2024 Aug 1;184(8):963-970. doi: 10.1001/jamainternmed.2024.1302.
4
[Application of the China-PAR risk prediction model for atherosclerotic cardiovascular disease in a rural northern Chinese population].中国-PAR动脉粥样硬化性心血管疾病风险预测模型在中国北方农村人群中的应用
Beijing Da Xue Xue Bao Yi Xue Ban. 2017 Jun 18;49(3):439-445.
5
Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China).预测中国人群动脉粥样硬化性心血管疾病 10 年风险:中国 PAR 项目(中国 ASCVD 风险预测)。
Circulation. 2016 Nov 8;134(19):1430-1440. doi: 10.1161/CIRCULATIONAHA.116.022367. Epub 2016 Sep 28.
6
Predicted Cardiovascular Risk by the PREVENT Equations in US Adults With Stage 1 Hypertension.美国 1 期高血压成年人中 PREVENT 方程预测的心血管风险。
Hypertension. 2024 Sep;81(9):1976-1985. doi: 10.1161/HYPERTENSIONAHA.124.22998. Epub 2024 Jul 15.
7
Ideal cardiovascular health and incidence of atherosclerotic cardiovascular disease among Chinese adults: the China-PAR project.中国成年人理想心血管健康与动脉粥样硬化性心血管疾病发病风险:中国前瞻性研究(China-PAR)。
Sci China Life Sci. 2018 May;61(5):504-514. doi: 10.1007/s11427-018-9281-6. Epub 2018 Mar 19.
8
Assessing Level of Agreement for Atherosclerotic Cardiovascular Disease Risk Categorization Between Coronary Artery Calcium Score and the American College of Cardiology/American Heart Association Cardiovascular Prevention Guidelines and the Potential Impact on Treatment Recommendations.评估冠状动脉钙化评分与美国心脏病学会/美国心脏协会心血管预防指南之间在动脉粥样硬化性心血管疾病风险分类上的一致性水平以及对治疗建议的潜在影响。
Am J Cardiol. 2016 Nov 15;118(10):1480-1485. doi: 10.1016/j.amjcard.2016.08.012. Epub 2016 Aug 23.
9
Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective Cohort.当代前瞻性队列中用于预测心血管风险的合并队列方程的评估
Am J Cardiol. 2017 Mar 15;119(6):881-885. doi: 10.1016/j.amjcard.2016.11.042. Epub 2016 Dec 18.
10
Performance of atherosclerotic cardiovascular risk prediction models in a rural Northern Chinese population: Results from the Fangshan Cohort Study.中国北方农村人群动脉粥样硬化性心血管病风险预测模型的表现:来自房山队列研究的结果。
Am Heart J. 2019 May;211:34-44. doi: 10.1016/j.ahj.2019.01.009. Epub 2019 Feb 5.

引用本文的文献

1
Healthy lifestyles and the incidence risk and time of carotid plaque: a nationwide cohort study.健康生活方式与颈动脉斑块的发病风险及时间:一项全国性队列研究。
BMC Public Health. 2025 Jul 15;25(1):2462. doi: 10.1186/s12889-025-23694-0.
2
A Systematic Review and Meta-Analysis of the Predictive Power of China-PAR Against Cardiovascular Disease.中国高血压知晓率、治疗率和控制率与心血管病关系的系统评价和 Meta 分析
Clin Med Res. 2024 Mar;22(1):28-36. doi: 10.3121/cmr.2024.1846.
3
Prevalence, awareness, treatment, and risk factor control of high atherosclerotic cardiovascular disease risk in Guangzhou, China.
中国广州动脉粥样硬化性心血管疾病高风险的患病率、知晓率、治疗率及危险因素控制情况
Front Cardiovasc Med. 2023 Jul 14;10:1092058. doi: 10.3389/fcvm.2023.1092058. eCollection 2023.
4
Normal-weight visceral obesity promotes a higher 10-year atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus-a multicenter study in China.正常体重内脏型肥胖会增加中国 2 型糖尿病患者 10 年内的动脉粥样硬化性心血管疾病风险:一项多中心研究。
Cardiovasc Diabetol. 2023 Jun 12;22(1):137. doi: 10.1186/s12933-023-01876-7.
5
Prevalence of Hypertension and 10-Year Cardiovascular Disease Risk Among Older Adults Living in Quanzhou, A Coastal Region of Southeast China.中国东南部沿海地区泉州市老年人高血压患病率及10年心血管疾病风险
Risk Manag Healthc Policy. 2022 May 13;15:1045-1053. doi: 10.2147/RMHP.S341148. eCollection 2022.
6
Predicting the risk of atherosclerotic cardiovascular disease among adults living with HIV/AIDS in Addis Ababa, Ethiopia: A hospital-based study.预测埃塞俄比亚亚的斯亚贝巴艾滋病病毒/艾滋病患者的动脉粥样硬化性心血管疾病风险:一项基于医院的研究。
PLoS One. 2021 Nov 29;16(11):e0260109. doi: 10.1371/journal.pone.0260109. eCollection 2021.
7
Value of 2 risk prediction models in predicting the risk of atherosclerosis in patients with chronic kidney disease.两种风险预测模型在预测慢性肾脏病患者动脉粥样硬化风险中的价值。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021;46(9):966-973. doi: 10.11817/j.issn.1672-7347.2021.200461.
8
Validating World Health Organization cardiovascular disease risk charts and optimizing risk assessment in China.验证世界卫生组织心血管疾病风险评估图表并优化中国的风险评估
Lancet Reg Health West Pac. 2021 Feb 5;8:100096. doi: 10.1016/j.lanwpc.2021.100096. eCollection 2021 Mar.
9
Prevalence of dyslipidemia and prediction of 10-year CVD risk among older adults living in southeast coastal regions in China: a cross-sectional study.中国东南沿海地区老年人血脂异常患病率及 10 年 CVD 风险预测:一项横断面研究。
Clin Interv Aging. 2019 Jun 20;14:1119-1129. doi: 10.2147/CIA.S207665. eCollection 2019.